Skin, hair follicles, joints, and connective tissue throughout the body all benefit from circulating GHK-Cu, which somewhat undercuts the case for a localized injection in the first place
Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, et al
Using it consistently during the GLP-1 window builds the pattern before the drug's appetite suppression ends
Regular exercise improves immune surveillance, gut motility, and hormonal balance, helping keep candida under control
Clinical Evidence and Current Research Status Published studies on GHK-Cu focus primarily on fibroblast activation, collagen synthesis promotion, and angiogenesis in vitro
DSIP is not FDA-approved for any indication, is not approved in the EU, UK, or other major regulated markets, and is sold as a research chemical only